Lucinda Orsini, DPM, MPH is vice president for value and outcomes research at COMPASS Pathways – a mental healthcare company dedicated to delivering innovative evidence-based treatment for people suffering from severe mental illness. She has a professional medical degree from Temple University College of Podiatric Medicine and a Masters in Public Health from the Harvard School of Public Health. Lucinda has spent approximately 20 years working and leading teams in the HEOR space in roles ranging from consulting at The Medstat Group (now Merative) and Parexel, working in large life sciences companies specifically Bristol-Myers Squibb, holding the role of associate chief science officer ISPOR for approximately 3 years, and currently in small precommercial pharmaceutical development.
Dr Orsini’s interest in outcomes research and its application to understanding the economics of healthcare provision and evidence-based decision making is what lead to her to the HEOR space. She has worked extensively in most areas of HEOR including economic modeling, patient-reported outcomes, and real-world evidence including comparative effectiveness. With over 20 publications and 40 presentations on relevant topics in this area, her research has been published in such journals as Value in Health, Pharmacoepidemiology and Drug Safety, Journal of Clinical Oncology, and the Journal of Medical Economics including most recently as an author on the publication “HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects.”
As past associate chief science officer at ISPOR, she was instrumental in developing the real-world evidence transparency initiative which has grown into a joint task force with ISPE on standardizing protocol templates for real-world data studies. Lucinda remains engaged with ISPOR co-chairing the RWE Special Interest Group, continuing to participate on the RWE steering committee, and representing ISPOR’s interest in the continuing joint task force with ISPE regarding protocol harmonization and registration for RWE studies. She has also participated in reviewing/rating meeting abstracts and posters.
ISPOR Vision Statement by Lucinda Orsini
Evidence-based medical decision making has always been important to me. During my medical training, I always wanted to understand the evidence that was available to help physicians make treatment decisions, it’s what led me to HEOR. The tools and techniques that come together under the science of health economics and outcomes research places us squarely at the nexus of medical decision making, whether it’s to support product development, learning healthcare systems, patient and provider decision making, regulatory or coverage decisions. The power of this discipline, and consequently ISPOR, resides in the multifaceted backgrounds and work environments of the scientists and members. I believe that my varied experiences in work setting and roles makes me well suited to represent members’ interests on the Board of Directors.
I also have a deep appreciation of how this Society functions from an internal and external (member) perspective, and have a unique understanding of the Society’s mission which resonates with me personally. The strategic pillars of communication and collaboration, scientific and research excellence, education and training, and member engagement are key areas of focus that will continue to drive the success of ISPOR as a professional society. They are anchored around the organizational values that we as members strive to uphold. During my time as ISPOR associate chief science officer I was privileged to help craft the Society’s vision of the future of HE+OR how we will continue to make an impact on healthcare systems and the multistakeholder community that we represent. I am committed to upholding our values as we also strive to continue forge new opportunities for the multidisciplinary science of health economics and outcomes to inform medical decision making.
I would be honored to represent you, the members of ISPOR, to continue the work of implementing the ISPOR strategic plan and moving HEOR toward the Societies’ future vision of increasing impact on healthcare systems and the multistakeholder community, while keeping our organizational values at the fore of our actions. We have a remarkable opportunity to continue to evolve as a discipline and a professional community – I am ready to help us continue to move in this direction.